{
    "code": "02020021",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020021",
    "time": "2018-05-11 03:57:53",
    "許可證字號": "衛署藥輸字第020021號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/07\/29",
    "發證日期": "107\/03\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202002100",
    "中文品名": "培爾吉平注射液１毫克\/毫升",
    "英文品名": "PERDIPINE INJECTION 1MG\/ML",
    "適應症": "適用於當口服治療不可行或不合適時、對高血壓的短期處置。",
    "劑型": "270注射劑",
    "包裝": "2公撮及10公撮安瓿 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "NICARDIPINEHCL"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620110R660  台灣安斯泰來製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260628000  NIPRO PHARMA CORPORATION ISE PLANT",
        "製造廠廠址": "647-240, Ureshinotengeji-cho, Matsusaka-shi, Mie 515-2302, Japan",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412001410",
            "成分名稱": "NICARDIPINE HCL",
            "含量描述": "1",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛署藥輸字第020021號培爾吉平注射液仿單-104-05-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020021&Seq=007&Type=9"
        },
        {
            "title": "培爾吉平注射液1毫克-毫升外盒(PDI-C1504-03)-104-10-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020021&Seq=001&Type=8"
        }
    ]
}